Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Medirista Biotechnologies AB
AB
Active
Org 5568089386
Karlbergsvägen 40, 113 27
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2010
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Medirista Biotechnologies AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
90
56
669
150
430
Staff expenses
—
—
—
—
—
EBITDA
60
6
420
128
410
Depreciation & amort.
−67
−67
−67
−67
−67
EBIT
−7
−61
353
62
344
Net financials
—
—
—
−3
−1
Profit before tax
−7
−61
353
59
343
Tax
−0
−0
−0
—
—
Net profit
−7
−61
353
59
343
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
903
837
937
830
1 118
Equity
413
352
705
764
1 107
Long-term debt
0
0
117
12
0
Short-term debt
490
485
115
54
11
Total debt
490
485
232
66
11
Financial ratios
5-year trend
EBITDA margin
95.4%
This company
15.8%
Market median
+504% vs market
2021
2025
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
2021
2025
Return on equity
31.0%
This company
18.4%
Market median
+68% vs market
2021
2025
Net profit margin
79.7%
This company
8.1%
Market median
+884% vs market
2021
2025
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Medirista Biotechnologies AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
